Leerink Partnrs Predicts Geron’s Q4 Earnings (NASDAQ:GERN)
Geron Co. (NASDAQ:GERN – Free Report) – Equities researchers at Leerink Partnrs dropped their Q4 2025 EPS estimates for shares of Geron in a note issued to investors on Wednesday, February 26th. Leerink Partnrs analyst F. Khurshid now forecasts that the biopharmaceutical company will post earnings of ($0.01) per share for the quarter, down from […]
Geron Co. (NASDAQ:GERN – Free Report) – Equities researchers at Leerink Partnrs dropped their Q4 2025 EPS estimates for shares of Geron in a note issued to investors on Wednesday, February 26th. Leerink Partnrs analyst F. Khurshid now forecasts that the biopharmaceutical company will post earnings of ($0.01) per share for the quarter, down from […]